Informations techniques
Exploitant
IDORSIA PHARMACEUTICALS FRANCE SAS
Présentation
QUVIVIQ 25 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 0 2)
QUVIVIQ 50 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 2 6)
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
at7WY4A1vqYNr9pG